Big pharmaceutical companies have failed to innovate and develop better ways to address gout for over 40 years. Recognizing that the human GI tract has a massively underused potential for uric acid elimination, we realized that we could take advantage of this using microbes engineered to take up and break down uric acid.
We are creating next-generation probiotics that are affordable, accessible, and broadly effective. We solve your gout using engineered probiotics and cutting-edge biotechnology.
Theraneutrics is developing Krystalase, a patent-pending probiotic supplement specifically engineered to take up and break down uric acid in the gut.
We are screening dozens of prototypes to optimize performance and identify the most effective active ingredient for Krystalase. We are currently in the R&D phase to rigorously prove Krystalase is safe for your liver, kidneys, and rest of your body, and is effective in breaking down uric acid.
People with gout will be able to benefit from our proprietary technology exclusively through Krystalase.
Theraneutrics was founded in 2018 and is currently working hard to solve your gout through diligent scientific research and development. We expect Krystalase to be available in U.S. markets mid-late 2022. Join our mailing list to keep up with our progress and be first in line to purchase Krystalase.